Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy.
about
Insulin resistance in patients with chronic kidney diseaseCurrent status of bicarbonate in CKDAutophagy-regulating TP53INP2 mediates muscle wasting and is repressed in diabetesProfiling of the renal kinome: a novel tool to identify protein kinases involved in angiotensin II-dependent hypertensive renal damagePhysical inactivity: a risk factor and target for intervention in renal care.Insulin resistance in chronic kidney disease: a systematic review.Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profileUrea-induced ROS generation causes insulin resistance in mice with chronic renal failure.Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophyCombined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease.Pathogenesis of insulin resistance in skeletal muscle.Caspase-3 cleaves specific 19 S proteasome subunits in skeletal muscle stimulating proteasome activity.FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1/MAFbx expression during glucocorticoid-induced skeletal muscle atrophyMuscle atrophy in chronic kidney disease results from abnormalities in insulin signaling.Fatty acids increase glucose uptake and metabolism in C2C12 myoblasts stably transfected with human lipoprotein lipase.Melanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease.Metabolic syndrome and chronic kidney disease: Current status and future directions.Silencing Myostatin Using Cholesterol-conjugated siRNAs Induces Muscle GrowthNutritional intervention restores muscle but not kidney phenotypes in adult calcineurin Aα null mice.Mechanisms of muscle wasting in chronic kidney diseaseNatural history of skeletal muscle mass changes in chronic kidney disease stage 4 and 5 patients: an observational studyPharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease.Protein-energy wasting and mortality in chronic kidney disease.Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models.Physical Activity in the Prevention of Chronic Kidney DiseaseXIAP reduces muscle proteolysis induced by CKD.Serum bicarbonate levels and the progression of kidney disease: a cohort study.Decreased miR-29 suppresses myogenesis in CKD.Body composition and survival in dialysis patients: results from an international cohort study.Effects of alkali supplementation and vitamin D insufficiency on rat skeletal muscle.Targeting the myostatin signaling pathway to treat muscle wasting diseasesMetabolic and morphometric profile of muscle fibers in chronic hemodialysis patients.Ammonium Chloride Ingestion Attenuates Exercise-Induced mRNA Levels in Human Muscle.Leucine disposal rate for assessment of amino acid metabolism in maintenance hemodialysis patients.Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486.Insulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis.Muscle wasting in chronic kidney disease: the role of the ubiquitin proteasome system and its clinical impact.p-Cresyl sulfate promotes insulin resistance associated with CKDCKD Stimulates Muscle Protein Loss Via Rho-associated Protein Kinase 1 Activation.C1-Ten is a protein tyrosine phosphatase of insulin receptor substrate 1 (IRS-1), regulating IRS-1 stability and muscle atrophy.
P2860
Q21285003-45259DBD-E570-4933-99AD-E3DBC862D980Q27015082-6D56927C-BF3D-4ACC-AB9F-59EB84923D8BQ28510496-8E09AEEE-8E4B-4B35-9C20-035F4AF2F319Q28583646-5E54E1E5-FA76-42FA-9E97-C68116E98251Q30238711-A74D4C9A-B09D-4D98-A042-4BA013BB6906Q30244271-123B9DE5-C9A9-4B9E-A400-3E6FEB2A09FAQ30440296-FAFF720C-E337-4E5F-A5FF-635A4FC9ED10Q33559582-2EBECB4E-54ED-4755-9B8C-6FA372F9A2D9Q33702390-DF5935AA-4529-4057-8E1E-442099D1D099Q33802142-A876D4A5-D3EE-4A29-BB62-88396D731DB6Q33812448-C5CB554D-4EDB-498A-8A2D-6E3766D44804Q33967411-5F784E07-B101-45C9-A785-2F8DB0771F9FQ34017130-1B76903B-28C5-42A3-AFF0-5E0437FEFA77Q34117352-9F5F2303-9190-4B33-BCE3-90A85AB5F6B1Q34215206-D7BF4945-D5FF-4841-822B-C08F80B923DAQ34390204-9425C2C1-2A0A-4A14-88E3-80330FDAB4BBQ34453266-44F8A71A-A5BD-411B-A2EC-CBC89D20BB85Q34536058-AA5A9C53-1AB6-4511-B636-268E04A36111Q34701648-85972F20-7CE6-4EBF-B525-E0AAB9F22869Q34723810-27A191B2-4DC0-4F07-BBEF-756F6C29D603Q34761344-A32644F9-24D3-4B8D-8DEC-7DB2E1A029A4Q34813421-33A63310-96F8-475A-AA94-0A12EFACFBCDQ35024794-6E7381AD-2FAB-43BC-A24D-25D7A323DCFDQ35128706-8B93D383-4C2C-4249-8DF1-4E43D696820CQ35149800-D82AAF10-23D7-4E77-9C2D-0979F0982367Q35153178-12B4B648-3E46-45C3-8948-0B023FE7BF86Q35163009-E87AA326-57E7-48B0-B3E1-27F1D10699C4Q35595507-339308E4-F8AF-453F-BDFF-A5C0C5AFDF66Q35611214-49EEFC0B-17A9-4CC9-9129-DE3680D47561Q35619109-5F4E5249-978A-48E3-AE10-2FD026D731DDQ35739702-EA741826-F480-4C98-8168-B2E57219F0B2Q35790188-649D37A6-3FD9-4AED-97D3-D9180CE1928AQ35866259-2A611FF0-EAFC-44B5-A34D-2EFFC7CBBE20Q36076978-92339314-8513-470A-93E3-23FF4A916E26Q36087285-E391B213-9655-46B1-BF69-431FF978A8EEQ36369287-477BE956-BEAB-419E-8C42-C0646FBC5078Q36484792-18D06E34-30F4-42E2-A151-F2160CC2EE4BQ36509307-BA6F55E8-EF1B-4C41-AD8C-A10AD6F65A3AQ36514936-1DB62572-2013-4CCB-B2A3-087C1FF29C7CQ36759853-30700739-229B-40ED-917A-FD28B9F8E0EE
P2860
Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Chronic kidney disease causes ...... plications for muscle atrophy.
@en
Chronic kidney disease causes ...... plications for muscle atrophy.
@nl
type
label
Chronic kidney disease causes ...... plications for muscle atrophy.
@en
Chronic kidney disease causes ...... plications for muscle atrophy.
@nl
prefLabel
Chronic kidney disease causes ...... plications for muscle atrophy.
@en
Chronic kidney disease causes ...... plications for muscle atrophy.
@nl
P2093
P356
P1476
Chronic kidney disease causes ...... plications for muscle atrophy.
@en
P2093
James L Bailey
S Russ Price
William E Mitch
Zhaoyong Hu
P304
P356
10.1681/ASN.2004100842
P577
2006-04-12T00:00:00Z